25 participants
Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-09-02
- Start Date:
- 2020-12-10
- Completion:
- 2021-08-24
Conditions
- CoronaVirus Disease-2019 (COVID-19)
Interventions
- DRUG
No Results Yet